Lung infusion for colorectal cancer that has spread to the lungs
Treatments studied
Part of Bones, joints & muscles, Cancer, Digestive system clinical trials.
This trial tests a procedure where chemotherapy is delivered directly into the lungs during surgery to remove or destroy lung tumors. It aims to reduce the chance of cancer returning after surgery for people with colorectal cancer that has spread to the lungs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have colorectal cancer that has spread to your lungs and the lung tumors can be removed or destroyed with surgery or other methods.
- You are generally able to care for yourself (ECOG performance status of 2 or less).
- Your blood counts and kidney function are within acceptable levels.
- Your lungs are healthy enough for surgery, as determined by your surgeon.
- You have not had chemotherapy or radiation in the last 4 weeks (or 6 weeks for certain drugs).
- You do not have brain metastases, severe nerve damage, or allergies to chemotherapy drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 trial tests a targeted treatment delivered to the lungs for colorectal cancer that has spread to the lungs. It aims to see if the approach is safe and can reach lung tumors, especially when there are multiple lung lesions.
This trial tests whether giving chemotherapy directly into the liver after surgery can lower the chance of cancer coming back. It is for people who had multiple liver tumors removed and whose cancer did not grow during pre-surgery chemo.
This trial tests whether adding two targeted drugs (serplulimab and bevacizumab) to standard chemotherapy before surgery can improve outcomes for people with colorectal cancer that has spread to the liver. It is for those whose cancer has certain genetic features and is considered resectable.
This early-phase study tests a special way to deliver medicine directly to the lungs (called IVLP) for sarcoma that has spread to both lungs. It aims to control lung metastases while reducing side effects, and it uses a plan that often includes surgery or focused radiation around the procedure.
This trial tests combining focused radiation (SBRT) with immunotherapy for colorectal cancer that has spread to the liver or lungs. The goal is to see if this combination can shrink tumors and improve control of the cancer.
This trial tests a new treatment for a type of lung cancer that has grown into the chest wall or nearby blood vessels. It combines radiation therapy, the immunotherapy drug durvalumab, and surgery, and researchers want to see if it is safe and effective.
Hear when a new Metastatic Malignant Neoplasm in the Lung trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.